NCT06937086

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-06-26Est. Completion: 2028-04

Enrollment target: 350 participants

Locations

Digestive Health Specialists, Dothan, Alabama, United States
Smart Cures Clinical Research, Anaheim, California, United States
Cedars-Sinai Medical Center, Beverly Hills, California, United States
United Medical Doctors - Los Alamitos, Los Alamitos, California, United States
California Medical Research Associates, Northridge, California, United States
Research Associates of South Florida - Miami - Southwest 8th Street, Miami, Florida, United States
Gastro Health Research - Miami, Miami, Florida, United States
Orlando Health, Orlando, Florida, United States
Digestive and Liver Center of Florida, Orlando, Florida, United States
Gastro Health Research - Pensacola, Pensacola, Florida, United States
Precision Clinical Research, Sunrise, Florida, United States
Grand Teton Research Group, Idaho Falls, Idaho, United States
Rush University Medical Center, Chicago, Illinois, United States
Indiana University Health University Hospital, Indianapolis, Indiana, United States
Gastroenterology Health Partners, New Albany, Indiana, United States

Ulcerative Colitis

The purpose of this research study is to test the efficacy and safety of the study intervention, CurQD or placebo (non-a…

New York, United StatesEst. completion Jun 23, 2027

Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis

Background: Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …

Bethesda, United StatesEst. completion Jun 1, 2036

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.